A nested case-control study of kidney cancer among refinery-petrochemical workers

Environmental Health Perspectives

Volumn 104, Issue 6, 1996, Pages 642-650

  Gamble, John F ^a   Pearlman, Eileen D ^a   Nicolich, Mark J ^a  

^a EXXONMOBIL UPSTREAM RESEARCH COMPANY   (United States)

Author keywords

Blood pressure; Case control study; Kidney cancer; Petrochemical workers; Petroleum hydrocarbons; Refinery workers; Smoking

Indexed keywords

ALKENE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; KIDNEY CANCER; MULTIVARIATE ANALYSIS; OCCUPATIONAL CANCER; OCCUPATIONAL EXPOSURE; PETROCHEMICAL INDUSTRY; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR; SMOKING;

EID: 0030036445     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.96104642     Document Type: Article

References (49)

1. Hanis NM, Shallenberger LG, Donaleski D, Sales EA. A retrospective mortality study of workers in three major U.S. refineries and chemical plants, part I: comparisons with U.S. population, J Occup Med 27:283-292 (1985).
2. Shallenberger LG, Acquavella JF, Donaleski D. An updated mortality study of workers in three major U.S. refineries and chemical plants. Br J Ind Med 49:345-354 (1992).
3. Gamble JF. Are petroleum hydrocarbons a kidney carcinogen in humans? A review of the epidemiologic evidence. Int Arch Occup Environ Health (in press).
4. Wong O, Raabe GK. Critical review of cancer epidemiology in petroleum industry employees, with a quantitative meta-analysis by cancer site. Am J Ind Med 15:283-310 (1989).
5. Poole C, Dreyer NA, Satterfield MH, Levin L, Rothman KJ. Kidney cancer and hydrocarbon exposures among perroleum refinery workers-Environ Health Perspect 101 (suppl 6):53-62 (1993).
6. Wen CP. Epidemiological studies of the role of gasoline (hydrocarbon) exposure in kidney cancer risk. Adv Mod Environ Toxicol 7:245-258 (1984).
7. Siemiarycki J, ed. Risk facrors for cancer in the workplace. Boston, MA:CRC Press, 1991.
8. Borghoff SJ, Short BG, Swenberg JA. Biochemical mechanisms and pathobiology of α2μ-globulin nephropathy. Annu Rev Pharmacol Toxicol 30:349-367 (1990).
9. Hard GC, Rodgers JS, Baetcke KP, Richards WL, McGaughy RE, Valcovic LR. Hazard evaluation of chemicals that cause accumulation of α2μ-globulin, hyalin droplet nephropathy, and tubule neoplasia in the kidneys of male rats. Environ Health Perspect 99:313-349 (1993).
10. Swenberg JA, Short B, Borghoff SJ, Strasser J, Charbonneau M. The comparative pathobiology of α2μ-globulin nephropathy. Toxicol Appl Pharmacol 97:35-46 (1989).
11. Melnick RL. Mechanistic data in scientific public health decisions. Regul Toxicol Pharmacol 16:109-110 (1992).
12. Melnick RL. An alternative hypothesis on the role of chemically induced protein droplet (α2μ-globulin) Nephroparhy in renal carcinogenesis. Regul Toxicol Pharmacol 16:111-125 (1992).
13. 2μ-globulin: association with chemically induced tenal toxicity and neoplasm in the male rat. EPA/625/3-91/019P. Washington, DC:Environmental Protection Agency, 1991.
14. McLaughlin JD, Mandel JS, Blot WJ, Schuman LM, Mehl ES, Fraumeni JF. A population-based case-control study of renal cell carcinoma. J Natl Cancer Inst 72:275-284 (1984).
15. Yu MC, Mack TM, Hanisch R, Cicioni C, Henderson BE. Cigarette smoking, obesity, diuretic use, and coffee consumption as risk factors for renal cell carcinoma. J Natl Cancer Inst 77:351-356 (1986).
16. Maclure KM, Willett W. A case-control study of diet and risk of renal adenocarcinoma. Epidemiology 1:430-440 (1990).
17. Goodman MT, Morgenstein H, Wynder EL. A case-control study of factors affecting the development of renal cell cancer. Am J Epidemiol 124:926-941 (1986).
18. Partanen T, Heikkila P, Hernberg S et al. Renal cell carcinoma and occupational exposure to chemical agents. Scand J Work Environ Health 17:231-239 (1991).
19. Asal NR, Risser DR, Kadamani S, Geyer JR, Lee ET, Cherng N. Risk factors in renal cell carcinoma: I. Methodology, demographics, tobacco, beverage, use and obesity. Cancer Detect Prevent 11:359-377 (1988).
20. Asal NR, Lee ET, Geyer JR, Kadamani S, Risser DR, Cherng N. Risk factors in renal cell carcinoma: II. Medical history, occupation, multivariate analysis, and conclusions. Cancer Detect Prevent 13:263-279 (1988).
21. Kadamani S, Asal NR, Nelson RY. Occupational hydrocarbon exposure and risk of renal cell carcinoma. Am J Ind Med 15:131-141 (1989).
22. Fraser GE, Phillips RL, Beeson WL. Hypertension, antihypertension medication and risk of renal carcinoma in California Seventh Day Adventists. Int J Epidemiol 19:832-838 (1990).
23. Wynder EL, Mabuchi K, Whitmore WF. Epidemiology of adenocarcinoma of the kidney. J Natl Cancer Inst 53:1619-1634 (1974).
24. Raynor WJ, Shekelle RB, Rossof AH, Maliza C, Paul O. High blood pressure and 17-year cancer mortality in the Western Electric health study. Am J Epidemiol 113:317-377 (1981).
25. Bennington JL, Laubscher FA. Epidemiologic studies on carcinoma of the kidney, I. Association of renal adenocarcinoma with smoking. Cancer 21:1069-1071 (1968).
26. Domiano SF, Vena JF, Swanson MK. Gasoline exposure, smoking and kidney cancer. J Occup Med 27:398-399 (1985).
27. Brownson RC. A case-control study of renal cell carcinoma in relation to occupation, smoking and alcohol consumption. Arch Environ Health 43:238-241 (1988).
28. McCredie M, Ford JM, Stewart JH. Risk factors for cancer of the renal parenchyma. Int J Cancer 42:13-16 (1988).
29. Armstrong B, Garrod A, Doll R. A retrospective study of renal cancer with special references to coffee and animal protein consumption. Br J Cancer 33:127-136 (1976)
30. Weir JM, Dunn JE. Smoking and mortality: a prospective study. Cancer 25:105-112 (1970).
31. Doll R, Peto R. Mortality in relation to smoking: 20 years observation on male British doctors. Br Med J 2:1525-1536 (1976).
32. Williams RR, Horm JW. Association of cancer sites with tobacco and alcohol consumption and socioeconomic status of patients: interview study from the Third National Cancer Survey. J Natl Cancer Inst 58.525-547 (1977).
33. Hirayama T. Life-style and mortality: a largescale census-based cohort study in Japan. New York:Karger, 1990.
34. Checkoway H. Methods of treatment of exposure data in occupational epidemiology. Med Lav 77:48-73 (1986).
35. West KM. Computing and expressing degree of fatness. J Am Med Assoc 243:1421-1422 (1980).
36. Halder CA, Holdsworth CE, Cockrell BV, Piccirillo VJ. Hydrocarbon nephropathy in male rats; identification of the nephrotoxic components of unleaded gasoline. Toxicol Ind Health 1:67-87 (1985).
37. Percy C, Stanek E, Gloeckler L. Accuracy of cancer death certificates and its effect on cancer mortality statistics. Am J Public Health 79:242-250 (1981).
38. Copeland KT, Checkoway H, Holbrook RH, McMichael AJ. Bias due to misclassification in the estimate of relative risk. Am J Epidemiol 105:488-495 (1977).
39. Marshall JR, Priore R, Graham S, Brasure J. On the distortion of risk estimate in multiple exposure level case-control studies. Am J Epidemiol 113:464-473 (1981).
40. Maclure KM. Asbestos and renal adenocarcinoma: a case-control study. Environ Res 42: 353-361 (1987).
41. Smith AH, Shearn VI, Wood R. Asbestos and kidney cancer: the evidence supports a causal association. Am J Ind Med 16:159-666 (1989).
42. Edelman DA. Does asbestos exposure increase the risk of urogenital cancer? Int Arch Occup Environ Health 63:469-475 (1992).
43. Armenian HK, Lilienfeld AM. The distribution of incubation periods of neoplastic disease. Am J Epidemiol 99:92-100 (1974).
44. Armenian HK, Lilienfeld AM. Incubation period of disease. Epidemiol Rev 5:1-15 (1983).
45. Armenian HK, Khoury MJ. Age at onset of genetic disease. Am J Epidemiol 113:596-605 (1981).
46. Grove JS, Nomura A, Severson RK, Stemmermann GN. The association of blood pressure with cancer incidence in a prospective study. Am J Epidemiol 134:942-947 (1991).
47. McLaughlin JD, Blot WJ, Fraumeni JF. Diuretics and renal cell cancer (letter). J Natl Cancer Inst 80:378 (1988).
48. Kolonel LN. Association of cadmium with renal cancer. Cancer 37:1782-1787 (1976).
49. Maclure KM, MacMahon B. A case-control study of renal adenocarcinoma [abstract]. Am J Epidemiol 122:520 (1985).